BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 31112983)

  • 1. Staphylococcus epidermidis: A Potential New Player in the Physiopathology of Acne?
    Claudel JP; Auffret N; Leccia MT; Poli F; Corvec S; Dréno B
    Dermatology; 2019; 235(4):287-294. PubMed ID: 31112983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electricity-producing Staphylococcus epidermidis counteracts Cutibacterium acnes.
    Marito S; Keshari S; Traisaeng S; My DTT; Balasubramaniam A; Adi P; Hsieh MF; Herr DR; Huang CM
    Sci Rep; 2021 Jun; 11(1):12001. PubMed ID: 34099817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Microtube Array Membrane (MTAM) Encapsulated Live Fermenting Staphylococcus epidermidis as a Skin Probiotic Patch against Cutibacterium acnes.
    Yang AJ; Marito S; Yang JJ; Keshari S; Chew CH; Chen CC; Huang CM
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes.
    Wang Y; Kao MS; Yu J; Huang S; Marito S; Gallo RL; Huang CM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
    Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
    J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutibacterium acnes and Staphylococcus epidermidis: the unmissable modulators of skin inflammatory response.
    Dagnelie MA; Corvec S; Timon-David E; Khammari A; Dréno B
    Exp Dermatol; 2022 Mar; 31(3):406-412. PubMed ID: 34674324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris.
    Wang Y; Kuo S; Shu M; Yu J; Huang S; Dai A; Two A; Gallo RL; Huang CM
    Appl Microbiol Biotechnol; 2014 Jan; 98(1):411-24. PubMed ID: 24265031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
    BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris.
    O'Neill AM; Gallo RL
    Microbiome; 2018 Oct; 6(1):177. PubMed ID: 30285861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis.
    Christensen GJ; Scholz CF; Enghild J; Rohde H; Kilian M; Thürmer A; Brzuszkiewicz E; Lomholt HB; Brüggemann H
    BMC Genomics; 2016 Feb; 17():152. PubMed ID: 26924200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culturable bacteria in the entire acne lesion and short-chain fatty acid metabolites of Cutibacterium acnes and Staphylococcus epidermidis isolates.
    Huang TY; Jiang YE; Scott DA
    Biochem Biophys Res Commun; 2022 Sep; 622():45-49. PubMed ID: 35843093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study.
    Karoglan A; Paetzold B; Pereira de Lima J; Brüggemann H; Tüting T; Schanze D; Güell M; Gollnick H
    Acta Derm Venereol; 2019 Dec; 99(13):1253-1257. PubMed ID: 31573666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acne microbiome: From phyla to phylotypes.
    Dreno B; Dekio I; Baldwin H; Demessant AL; Dagnelie MA; Khammari A; Corvec S
    J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):657-664. PubMed ID: 37777343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial skin commensals and their role as host guardians.
    Christensen GJ; Brüggemann H
    Benef Microbes; 2014 Jun; 5(2):201-15. PubMed ID: 24322878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analyses of biofilm formation among different Cutibacterium acnes isolates.
    Kuehnast T; Cakar F; Weinhäupl T; Pilz A; Selak S; Schmidt MA; Rüter C; Schild S
    Int J Med Microbiol; 2018 Dec; 308(8):1027-1035. PubMed ID: 30268774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Skin Microbiome: A New Actor in Inflammatory Acne.
    Dréno B; Dagnelie MA; Khammari A; Corvec S
    Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):18-24. PubMed ID: 32910436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
    J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.